cll14 trial: obinutuzumab venetoclax vs obinutuzumab chlorambucil
Published 4 years ago • 232 plays • Length 4:30Download video MP4
Download video MP3
Similar videos
-
0:59
5-year follow-up results of cll14: obinutuzumab venetoclax vs obinutuzumab chlorambucil in cll
-
5:54
cll14: venetoclax plus obinutuzumab for cll
-
0:45
obinutuzumab and venetoclax for high-risk cll: upcoming cll14 trial
-
1:43
six-year update from cll14: fixed-duration venetoclax obinutuzumab for previously untreated cll
-
3:07
cll14 trial analysis
-
1:16
cll14: venetoclax-obinutuzumab improves pfs and mrd in untreated, reduced fitness cll
-
1:24
venetoclax plus obinutuzumab in ckt cll: analysis from the cll14 trial
-
1:14
cll14 trial thoughts
-
4:52
apoptosis and venetoclax
-
7:29
venetoclax obinutuzumab: impact on cll management
-
9:15
obinutuzumab venetoclax for frontline cll
-
5:59
6-year results of cll14: venetoclax-obinutuzumab for previously untreated cll
-
2:00
obinutuzumab, ibrutinib, and venetoclax in high-risk cll: the cll2-give and cll13 trials
-
1:52
evaluating the efficacy of obinutuzumab, ibrutinib, and venetoclax in richter's transformation
-
2:03
venetoclax and obinutuzumab combination therapy for cll
-
1:12
frontline, fixed-duration venetoclax/obinutuzumab: pfs and mrd data from cll14
-
3:34
glow: primary analysis of ibrutinib plus venetoclax versus obinutuzumab plus chlorambucil in cll
-
10:24
fixed-duration therapy with venetoclax-obinutuzumab in frontline cll
-
0:48
venetoclax and obinutuzumab for cll
-
2:11
atezolizumab with venetoclax and obinutuzumab in patients with cll
-
1:39
overview of the cllr3 trial of obinutuzumab
-
3:15
overview of a phase ib study of venetoclax and obinutuzumab in cll